Advertisement
| cancer is a business: The Cancer Industry: Crimes, Conspiracy and The Death of My Mother Mark Sloan, 2020-02-10 By the time you're done reading this book, you'll know: if surgery, chemotherapy or radiotherapy are effective treatments for cancer; if cancer screening programs save lives or result in mass over-diagnosis and over-treatment; if the cancer industry has suppressed cures or effective treatments from the public--Back cover. |
| cancer is a business: Delivering Affordable Cancer Care in the 21st Century Institute of Medicine, Board on Health Care Services, National Cancer Policy Forum, 2013-06-20 Rising health care costs are a central fiscal challenge confronting the United States. National spending on health care currently accounts for 18 percent of gross domestic product (GDP), but is anticipated to increase to 25 percent of GDP by 2037. The Bipartisan Policy Center argues that this rapid growth in health expenditures creates an unsustainable burden on America's economy, with far-reaching consequences. These consequences include crowding out many national priorities, including investments in education, infrastructure, and research; stagnation of employee wages; and decreased international competitiveness.In spite of health care costs that far exceed those of other countries, health outcomes in the United States are not considerably better. With the goal of ensuring that patients have access to high-quality, affordable cancer care, the Institute of Medicine's (IOM's) National Cancer Policy Forum convened a public workshop, Delivering Affordable Cancer Care in the 21st Century, October 8-9, 2012, in Washington, DC. Delivering Affordable Cancer Care in the 21st Century summarizes the workshop. |
| cancer is a business: The Changing Economics of Medical Technology Institute of Medicine, Committee on Technological Innovation in Medicine, 1991-02-01 Americans praise medical technology for saving lives and improving health. Yet, new technology is often cited as a key factor in skyrocketing medical costs. This volume, second in the Medical Innovation at the Crossroads series, examines how economic incentives for innovation are changing and what that means for the future of health care. Up-to-date with a wide variety of examples and case studies, this book explores how payment, patent, and regulatory policiesâ€as well as the involvement of numerous government agenciesâ€affect the introduction and use of new pharmaceuticals, medical devices, and surgical procedures. The volume also includes detailed comparisons of policies and patterns of technological innovation in Western Europe and Japan. This fact-filled and practical book will be of interest to economists, policymakers, health administrators, health care practitioners, and the concerned public. |
| cancer is a business: Cancer Rehabilitation Michael O'Dell, MD, Michael Stubblefield, MD, 2009-04-22 A Doody's Core Title 2012 This new comprehensive reference provides a state-of-the-art overview of the principles of cancer care and best practices for restoring function and quality of life to cancer survivors. Authored by some of the world« leading cancer rehabilitation experts and oncology specialists, the principles section provides primer level discussions of the various cancer types and their assessment and management. The practice section thoroughly explores the identification, evaluation, and treatment of specific impairments and disabilities that result from cancer and the treatment of cancer.This groundbreaking volume enables the entire medical team to provide superior care that results in a better quality of life for cancer survivors. Features include: Multi-specialty editorship and authorship from physiatry, oncology, physical therapy, occupational therapy,and related disciplines. Focus on therapeutic management of cancer-related impairments and complications. In-depth treatment of the medical, neurologic, musculoskeletal, and general rehabilitation issues specific to this patient population. |
| cancer is a business: Chris Beat Cancer Chris Wark, 2021-01-05 Now in paperback, the Wall Street Journal best-selling guide to charting a path from cancer to wellness through a toxin-free diet, lifestyle, and therapy--created by a colon cancer survivor. Millions of readers have followed Chris Wark's journey on his blog and podcast Chris Beat Cancer, and in his debut work, he dives deep into the reasoning and scientific foundation behind the approach and strategies that he used to successfully heal his body from stage-3 colon cancer. Drawing from the most up-to-date and rigorous research, as well as his deep faith, Wark provides clear guidance and continuous encouragement for his healing strategies, including his Beat Cancer Mindset; radical diet, and lifestyle changes; and means for mental, emotional, and spiritual healing. Packed with both intense personal insight and extensive healing solutions, the Wall Street Journal best-selling Chris Beat Cancer will inspire and guide you on your own journey toward wellness. |
| cancer is a business: The Truth in Small Doses Clifton Leaf, 2013-07-16 A decade ago Leaf, a cancer survivor himself, began to investigate why we had made such limited progress fighting this terrifying disease. The result is a gripping narrative that reveals why the public's immense investment in research has been badly misspent, why scientists seldom collaborate and share their data, why new drugs are so expensive yet routinely fail, and why our best hope for progress-- brilliant young scientists-- are now abandoning the search for a cure. |
| cancer is a business: Corporate Cancer Vox Day, 2019-11-17 The corporate cancer of social justice convergence is costing corporations literal billions of dollars even as it drives both productive employees and loyal customers away, destroys valuable brands, and eats away at market capitalizations. CORPORATE CANCER is a must-read for corporate employees, managers, and executives alike. |
| cancer is a business: The Comprehensive Cancer Center Mahmoud Aljurf, Navneet S. Majhail, Mickey B.C. Koh, Mohamed A. Kharfan-Dabaja, Nelson J. Chao, 2021-10-28 This open access book provides a valuable resource for hospitals, institutions, and health authorities worldwide in their plans to set up and develop comprehensive cancer care centers. The development and implementation of a comprehensive cancer program allows for a systematic approach to evidence-based strategies of prevention, early detection, diagnosis, treatment, and palliation. Comprehensive cancer programs also provide a nexus for the running of clinical trials and implementation of novel cancer therapies with the overall aim of optimizing comprehensive and holistic care of cancer patients and providing them with the best opportunity to improve quality of life and overall survival. This book's self-contained chapter format aims to reinforce the critical importance of comprehensive cancer care centers while providing a practical guide for the essential components needed to achieve them, such as operational considerations, guidelines for best clinical inpatient and outpatient care, and research and quality management structures. Intended to be wide-ranging and applicable at a global level for both high and low income countries, this book is also instructive for regions with limited resources. The Comprehensive Cancer Center: Development, Integration, and Implementation is an essential resource for oncology physicians including hematologists, medical oncologists, radiation oncologists, surgical oncologists, and oncology nurses as well as hospitals, health departments, university authorities, governments and legislators. |
| cancer is a business: Surviving the “Business” of Healthcare - Knowledge is Power! Barbara Galutia Regis, M.S., PA-C, 2018-11-21 Healthcare has changed immensely over the past few generations—house calls from a local family doctor are a thing of the past, and the deeply personal relationships and bonds between provider and patient are eroding with the demands of for-profit insurance. As a family practitioner focused on cradle-to-grave care, author Barb Regis has a valuable perspective on how patients can experience better outcomes. Topics addressed in this information-packed book include how to choose a primary care physician, how to plan for catastrophic healthcare costs, how to comparison shop for medication, and how to be an effective advocate for yourself and loved ones. As the daughter of a busy family doctor, Barb also shares vivid anecdotes from her childhood which illuminate the heart of a doctor’s calling and demonstrate how insurance can dictate and interfere with quality of care. This book is a must-read for everyone who wants to make informed, effective decisions about healthcare—knowledge is power! |
| cancer is a business: Guts Robert Nylen, 2009-05-26 “This is a memoir: a package of boasts, false modesty, flawed memories, dropped names, outright errors, and embarrassing disclosures that I think are pretty neat–but may appall you, if you’re squeamish or have an orderly turn of mind.”—Robert Nylen The thing is, Robert Nylen should have died several times in 1968. He was a goner in 2006, and 2007 as well, and yet he survived through a combination of dumb luck and sheer perseverance. Of course, as you read these words, he’s already bit the dust. But let’s not dwell on that. A self-confessed reckless jerk, Nylen spent the last four years of his life grappling with Big Diseases (cancer, diabetes), an astonishing twelve broken bones, and ten surgeries. His lifetime total is twenty-four fractures, most of which resulted from a flagrant refusal to act his age–or anyone’s age, for that matter. And yet Guts is not a mere chronicle of injuries but a sharp and wry meditation on American Manhood. Growing up in suburbia in the ’50s and ’60s, with a father who had worked on the atom bomb, Nylen was an immature kid who was always eager for attention. In college he became a slovenly, hard-partying fraternity brother who barely graduated. Then came the realization that he was going to have to go to Vietnam. A dramatic tour of duty came to an abrupt end with multiple wounds, leading him to grow up fast. It was then that he started the real risky business: business itself. Some ventures succeeded and some failed. He exercised feverishly and often displayed a complete lack of common sense. And then he got sick, inevitably, with colon cancer. Hilarious, moving, and riveting, this is the life of a tough guy as seen through the scope of a national obsession with toughness. Whether he was facing Viet Cong as a platoon leader in Vietnam or doing battle with venture capitalists at home, Nylen never backed down from a good fight–and he had the many scars to prove it. In Guts, Robert Nylen writes with humor and precision about the travails–and glory–of manhood. |
| cancer is a business: Magic Cancer Bullet Daniel Vasella, M.D., Robert Slater, 2003-06-03 History of the breakthrough of the cancer pill Gleevec. |
| cancer is a business: Principles of Cancer Treatment and Anticancer Drug Development Wolfgang Link, 2019-09-10 This book explains how current medicines against cancer work and how we find new ones. It provides an easy-to-understand overview of current options to treat patients with cancer, which includes Surgery, Radiation therapy, Chemotherapy, Targeted therapy and Immunotherapy. The efficiency of all these treatments is limited by the capacity of cancer cells to escape therapy. This book explains the mechanisms of anti-cancer drug resistance and strategies to overcome it. The discovery and development process of a new drug is detailed beginning with the identification and validation of a therapeutic target, the identification of an inhibitor of the target and its subsequent preclinical and clinical development until its approval by regulatory authorities. Particular emphasis has been given to specific aspects of the development process including lead generation and optimization, pharmacokinetics, ADME analysis, pharmacodynamics, toxicity and efficacy assessment, investigational new drug (IND) and new drug application (NDA) and the design of clinical trial and their phases. The book covers many aspects of modern personalized oncology and discusses economic aspects of our current system of developing new medicines and its impact on our societies and on future drug research. The author of this book, Dr. Link counts with more than 20 years of experience in biomedical research reflected in numerous publications, patents and key note and plenary presentations at international conferences. Interested readers, students and teachers should read this book as it provides a unique way to learn/teach about basic concepts in oncology and anti-cancer drug research. |
| cancer is a business: Cancer Control Opportunities in Low- and Middle-Income Countries Institute of Medicine, Board on Global Health, Committee on Cancer Control in Low- and Middle-Income Countries, 2007-01-26 Cancer is low or absent on the health agendas of low- and middle-income countries (LMCs) despite the fact that more people die from cancer in these countries than from AIDS and malaria combined. International health organizations, bilateral aid agencies, and major foundations—which are instrumental in setting health priorities—also have largely ignored cancer in these countries. This book identifies feasible, affordable steps for LMCs and their international partners to begin to reduce the cancer burden for current and future generations. Stemming the growth of cigarette smoking tops the list to prevent cancer and all the other major chronic diseases. Other priorities include infant vaccination against the hepatitis B virus to prevent liver cancers and vaccination to prevent cervical cancer. Developing and increasing capacity for cancer screening and treatment of highly curable cancers (including most childhood malignancies) can be accomplished using resource-level appropriateness as a guide. And there are ways to make inexpensive oral morphine available to ease the pain of the many who will still die from cancer. |
| cancer is a business: Steve Jobs Walter Isaacson, 2011 Based on more than 40 interviews with Jobs conducted over two years--as well as interviews with more than 100 family members, friends, adversaries, competitors, and colleagues--Isaacson has written a riveting story of the roller-coaster life and searingly intense personality of a creative entrepreneur whose passion for perfection and ferocious drive revolutionized six industries: personal computers, animated movies, music, phones, tablet computing, and digital publishing. |
| cancer is a business: The Emperor of All Maladies Siddhartha Mukherjee, 2011-08-09 Winner of the Pulitzer Prize and a documentary from Ken Burns on PBS, this New York Times bestseller is “an extraordinary achievement” (The New Yorker)—a magnificent, profoundly humane “biography” of cancer—from its first documented appearances thousands of years ago through the epic battles in the twentieth century to cure, control, and conquer it to a radical new understanding of its essence. Physician, researcher, and award-winning science writer, Siddhartha Mukherjee examines cancer with a cellular biologist’s precision, a historian’s perspective, and a biographer’s passion. The result is an astonishingly lucid and eloquent chronicle of a disease humans have lived with—and perished from—for more than five thousand years. The story of cancer is a story of human ingenuity, resilience, and perseverance, but also of hubris, paternalism, and misperception. Mukherjee recounts centuries of discoveries, setbacks, victories, and deaths, told through the eyes of his predecessors and peers, training their wits against an infinitely resourceful adversary that, just three decades ago, was thought to be easily vanquished in an all-out “war against cancer.” The book reads like a literary thriller with cancer as the protagonist. Riveting, urgent, and surprising, The Emperor of All Maladies provides a fascinating glimpse into the future of cancer treatments. It is an illuminating book that provides hope and clarity to those seeking to demystify cancer. |
| cancer is a business: SCAM Edzard Ernst, 2018-06-22 So-called alternative medicine (SCAM) is popular and therefore important, no matter whether we love or loathe it. Consequently, an impressive number of books about SCAM are already available. Most of them, however, are woefully uncritical, overtly promotional and dangerously misleading. Not so this one! This book was written by someone who received SCAM as a patient, practised SCAM as a doctor, and researched SCAM as a scientist. It provides an insider's perspective by covering aspects of SCAM which most other books avoid, and by questioning the many tacitly accepted assumptions and wild extrapolations that underpin SCAM. The text is factual, occasionally dosed with a touch of humour or satire. The aim is not only to inform but also to entertain. It is written principally for members of the general public who have an interest in healthcare and are tired of the promotional counter-knowledge produced by SCAM enthusiasts. It is an exercise in critical thinking that might prevent you from wasting your money on (or endangering your health with) bogus treatments. |
| cancer is a business: A New Deal for Cancer Abbe R. Gluck, Charles S Fuchs, 2021-11-16 An unprecedented constellation of experts—leading cancer doctors, policymakers, cutting-edge researchers, national advocates, and more—explore the legacy and the shortcomings from the fifty-year war on cancer and look ahead to the future. The longest war in the modern era, longer than the Cold War, has been the war on cancer. Cancer is a complex, evasive enemy, and there was no quick victory in the fight against it. But the battle has been a monumental test of medical and scientific research and fundraising acumen, as well as a moral and ethical challenge to the entire system of medicine. In A New Deal for Cancer, some of today’s leading thinkers, activists, and medical visionaries describe the many successes in the long war and the ways in which our deeper failings as a society have held us back from a more complete success. Together they present an unrivaled and nearly complete map of the battlefield across dimensions of science, government, equity, business, the patient provider experience, and more, documenting our emerging understanding of cancer’s many unique dimensions and offering bold new plans to enable the American health care system to deliver progress and hope to all patients. |
| cancer is a business: Cancer Hates Tea Maria Uspenski, 2016-12-13 Drink Tea to Tell Cancer ‘Hit the Road’ Become a tea lover with a purpose and help your body defend itself against cancer. Learn to embrace tea in all its varieties— green, white, black, pu-erh, herbal and more—as both a mental and physical experience to protect your health. Discover the history, growing information and health implications of each variety, as well as uniquely delicious methods to boost your intake with serving suggestions, food pairings and recipes that highlight the benefits of tea. After her own battle with cancer, Maria Uspenski extensively researched tea and discovered hundreds of studies that showed how powerful a five-cup-a-day (1.2 L) steeping habit could be. Tea is the most studied anti-cancer plant, with over 5,000 medical studies published on its health benefits over the past 10 years. By breaking down how tea works with your body’s defenses against cancer in a lighthearted tone, Maria’s serious research is approachable and relatable for anyone who is battling the disease or for family and friends of those fighting cancer. Start harnessing the wellness-promoting properties of tea and see your life change with an easy-to-follow three-week plan that gets tea polyphenols streaming through your system 24/7. |
| cancer is a business: The American Cancer Society's Principles of Oncology The American Cancer Society, 2018-03-20 Developed by the American Cancer Society this new textbook designed for a wide range of learners and practitioners is a comprehensive reference covering the diagnosis of cancer, and a range of related issues that are key to a multidisciplinary approach to cancer and critical to cancer control and may be used in conjunction with the book, The American Cancer Society's Oncology in Practice: Clinical Management. Edited by leading clinicians in the field and a stellar contributor list from the US and Europe, this book is written in an easy to understand style by multidisciplinary teams of medical oncologists, radiation oncologists and other specialists, reflecting day-to-day decision-making and clinical practice. Input from pathologists, surgeons, radiologists, and other specialists is included wherever relevant and comprehensive treatment guidelines are provided by expert contributors where there is no standard recognized treatment. This book is an ideal resource for anyone seeking a deeper understanding of cancer prevention, screening, and follow-up, which are central to the ACS's worldwide mission on cancer control. |
| cancer is a business: The Gerson Therapy Charlotte Gerson, Morton Walker, 2001 Offers a nutritional program that utilizes the healing powers of organic fruits and vegetables to reverse the effects of cancer and other illnesses. |
| cancer is a business: Constructions of Cancer in Early Modern England Alanna Skuse, 2015-11-11 This book is open access under a CC-BY licence. Cancer is perhaps the modern world's most feared disease. Yet, we know relatively little about this malady's history before the nineteenth century. This book provides the first in-depth examination of perceptions of cancerous disease in early modern England. Looking to drama, poetry and polemic as well as medical texts and personal accounts, it contends that early modern people possessed an understanding of cancer which remains recognizable to us today. Many of the ways in which medical practitioners and lay people imagined cancer – as a 'woman's disease' or a 'beast' inside the body – remain strikingly familiar, and they helped to make this disease a byword for treachery and cruelty in discussions of religion, culture and politics. Equally, cancer treatments were among the era's most radical medical and surgical procedures. From buttered frog ointments to agonizing and dangerous surgeries, they raised abiding questions about the nature of disease and the proper role of the medical practitioner. |
| cancer is a business: The American Cancer Society's Oncology in Practice The American Cancer Society, 2018-05-01 Developed by the American Cancer Society this new textbook designed for a wide range of learners and practitioners comprehensively addresses all aspects of clinical management for cancer taking a balanced, authoritative and, -where possible- evidence-based stance and may be used in conjunction with the book, The American Cancer Society's Principles of Oncology: Prevention to Survivorship. Edited by leading clinicians in the field and a stellar contributor list from the US and Europe, this book is written in an easy to understand style by multidisciplinary teams of medical oncologists, radiation oncologists and other specialists, reflecting day-to-day decision-making and clinical practice. Input from pathologists, surgeons, radiologists, and other specialists is included wherever relevant and comprehensive treatment guidelines are provided by expert contributors where there is no standard recognized treatment. This book is an ideal resource for anyone seeking a practical understanding of the field of oncology. |
| cancer is a business: Philosophy of Cancer Marta Bertolaso, 2016-08-24 Since the 1970s, the origin of cancer is being explored from the point of view of the Somatic Mutation Theory (SMT), focusing on genetic mutations and clonal expansion of somatic cells. As cancer research expanded in several directions, the dominant focus on cells remained steady, but the classes of genes and the kinds of extra-genetic factors that were shown to have causal relevance in the onset of cancer multiplied. The wild heterogeneity of cancer-related mutations and phenotypes, along with the increasing complication of models, led to an oscillation between the hectic search of ‘the’ few key factors that cause cancer and the discouragement in face of a seeming ‘endless complexity’. To tame this complexity, cancer research started to avail itself of the tools that were being developed by Systems Biology. At the same time, anti-reductionist voices began claiming that cancer research was stuck in a sterile research paradigm. This alternative discourse even gave birth to an alternative theory: the Tissue Organization Field Theory (TOFT). A deeper philosophical analysis shows limits and possibilities of reductionist and anti-reductionist positions and of their polarization. This book demonstrates that a radical philosophical reflection is necessary to drive cancer research out of its impasses. At the very least, this will be a reflection on the assumptions of different kinds of cancer research, on the implications of what cancer research has been discovering over 40 years and more, on a view of scientific practice that is most able to make sense of the cognitive and social conflicts that are seen in the scientific community (and in its results), and, finally, on the nature of living entities with which we entertain this fascinating epistemological dance that we call scientific research. The proposed Dynamic and Relational View of carcinogenesis is a starting point in all these directions. |
| cancer is a business: Patient Number One Rick Murdock, David Fisher, 2000 In Great Dames, Marie Benner introduces us to a pantheon of women whose lives are both gloriously individual and yet somehow universal. Her subjects range from Jacqueline Kennedy Onassis, who found happiness in her last decade, to Constance Baker Motley, who argued Brown versus the Board of Education before the United States Supreme Court, to Luise Rainer, who won two Academy Awards by age thirty, then fled Hollywood for good. We meet Kitty Carlisle Hart, a professional charmer and tireless advocate of the arts, and Diana Trilling, the intellectual's intellectual, who published her final, splendid memoir at age ninety-one. There are even the Becky Sharps, who maneuvered powerful men to help them ascend: Marietta Tree, Pamela Harriman, and Clare Boothe Luce. And the wonderfully flamboyant Kay Thompson, whose pint-sized creation, Eloise, gave her a place in American cultural history. Finally, there is Thelma Brenner, who was the first great dame her daughter ever knew. These are women who helped shape a century. Marie Brenner's portraits are intimate, vivid, and true, and full of subtle but important lessons. The way the great dames lived their lives - their rules, their codes, their insistence on certain fundamentals - are models that today's women should consider as they ascend to positions of leadership in a new millennium.--BOOK JACKET.Title Summary field provided by Blackwell North America, Inc. All Rights Reserved |
| cancer is a business: Cancer: The Enemy from Within Carolyn Compton, 2020-05-06 This comprehensive, ground-breaking title presents, in simplifying style, the driving and organizing principles of cancer, making this multidimensional, highly complex disease easily understandable for readers. Developed out of the renowned author’s many years of teaching a widely popular, several-hundred-student college course, this 12-chapter book begins with an account of the history of cancer as a medical and public health problem, as well as the major milestones and setbacks in the ongoing quest to understand the wide variety of cancers that continue to impact the world. Subsequent chapters then address pathogenesis, incidence and mortality statistics, risk factors, causal factors, screening challenges and victories, treatment strategies, and disease prevention approaches. This wealth of clinical information is further supplemented with socioeconomic discussions on the financial, social, ethical, technological, regulatory, political, and logistical challenges that limit progress in cancer research. A soon to be gold-standard text that thoroughly and expertly describes cancer as a composite, adaptive system, Cancer: The Enemy from Within equips and empowers all undergraduate students and graduate students to better understand this continually perplexing disease. Clinicians across all disciplines may also find this work of great interest. |
| cancer is a business: Molecular Therapies of Cancer Georg F. Weber, 2015-07-22 Molecular Therapies of Cancer comprehensively covers the molecular mechanisms of anti-cancer drug actions in a comparably systematic fashion. While there is currently available a great deal of literature on anti-cancer drugs, books on the subject are often concoctions of invited review articles superficially connected to one another. There is a lack of comprehensive and systematic text on the topic of molecular therapies in cancer. A further deficit in the relevant literature is a progressive sub-specialization that typically limits textbooks on cancer drugs to cover either pharmacology or medicinal chemistry or signal transduction, rather than explaining molecular drug actions across all those areas; Molecular Therapies of Cancer fills this void. The book is divided into five sections: 1. Molecular Targeting of Cancer Cells; 2. Emerging and Alternative Treatment Modalities; 3. Molecular Targeting of Tumor-Host Interactions; 4. Anti-Cancer Drug Pharmacokinetics; and 5. Supportive Therapies. |
| cancer is a business: Applications of Biotechnology in Neurology Kewal K. Jain, 2013-01-05 Culling together excerpts from a wide range of writings by Dr. Kewal K. Jain on biotechnology topics as they relate to disorders of the nervous system, Applications of Biotechnology in Neurology covers a variety of applications for those working in life sciences and the pharmaceutical sciences, particularly those developing diagnostics and therapeutics for the nervous system. This detailed volume delves into areas such as neurobiotechnology, like neurogenomics and neuroproteomics, molecular diagnostics, various methods of improving systemic administration of drugs for targeted delivery to the nervous system, including the use of nanobiotechnology, biotechnology-based strategies and products for neuroprotection, as well as chapters on neurosurgery and personalized neurology. Thorough, cutting-edge, and thoughtfully organized, Applications of Biotechnology in Neurology serves as an ideal guide, supplemented by 75 tables and 16 figures as well as numerous references from recent literature on this topic, which are appended to each chapter. |
| cancer is a business: Cancer Chemotherapy: an Introduction Terry J. Priestman, 2012-12-06 This book is intended as an introduction to the drug treatment of cancer. It is almost ten years since the last edition was written. In the intervening time, there have been numerous developments in cancer chemotherapy and in order to cover these the majority of the text has been completely revised and rewritten. In addition, two new chapters have been introduced, one on the safe handling of cytotoxic drugs and the other on biological response modifiers. In order to incorporate this new information without any undue increase in the length of the text the chapters on a combined approach to treatment have been omitted. This is not because interdisciplinary collaboration is no longer considered important but is a reflection of the fact that, in most centres, it has become the norm in cancer management and its central role in successful treatment no longer needs to be stressed quite so strongly. The four chapters in the last edition which dealt with the team approach to cancer therapy have been replaced by a single chapter on the place of chemotherapy in the overall treatment of cancer. Unfortunately, despite all the innovations of the last decade, it has become increasingly clear that much of the promise offered by drug treatment during the 1960s and 1970s has not been fulfilled. |
| cancer is a business: Lung Cancer and Personalized Medicine Aamir Ahmad, Shirish Gadgeel, 2015-12-14 This, the first of two volumes on personalized medicine in lung cancer, touches on the core issues related to the understanding of lung cancer—statistics and epidemiology of lung cancer—along with the incidence of lung cancer in non-smokers. A major focus of this volume is the state of current therapies against lung cancer—immune, targeted therapies against EGFR TKIs, KRAS, ALK, angiogenesis; the associated challenges, especially resistance mechanisms; and recent progress in targeted drug development based on metal chemistry. Chapters are written by some of the leading experts in the field, who provide a better understanding of lung cancer, the factors that make it lethal, and current research focused on developing personalized treatment plans. With a unique mix of topics, this volume summarizes the current state-of-knowledge on lung cancer and the available therapies. |
| cancer is a business: Advances in Cancer Treatment Iago Dillion Lima Cavalcanti, José Cleberson Santos Soares, 2021-02-24 This work covers the pathophysiology of cancer, exploring the difficulty of optimal treatment due to the complexity and diversity of cancer types. The search for distinctive molecular biology characteristics of tumor cells is especially relevant in the identification of overexpressed receptors and proteins that can be used as a target for cancer treatment. We highlight the main therapeutic modalities, particularly conventional systemic chemotherapy, addressing its mechanisms of action, therapeutic classes and even the toxic effects. We also describe the main tumor markers, their importance in the diagnosis and treatment of cancer, and the specificity of tumor cells. The first chapters serve as an introduction to the central topic of this book, targeted therapy. Key aspects of target therapy, such as classes of drugs, immunotherapy, monoclonal antibodies, checkpoint inhibitors, cancer vaccines and tyrosine kinase inhibitors are presented, and, for each one, the benefits, as well as the adverse effects are reported. Chapter 6 compares conventional systemic chemotherapy and targeted therapy, identifies the risks and benefits and also the eligibility criteria for patient care. The possibility of targeted therapy replacing conventional chemotherapy is discussed while reviewing studies that demonstrate the benefits of combining both types of treatment. Finally, the introduction of pharmaceutical nanotechnology to improve antineoplastic agents is addressed in the last chapter and sets the direction for future research in cancer treatment. This is a valuable resource for many health professionals including physicians, pharmacists, nurses, researchers and students interested in the field of oncology. |
| cancer is a business: Cancer on the Brain Jay Lefevers, 2012-06 |
| cancer is a business: The Undying Anne Boyer, 2019-09-17 WINNER OF THE 2020 PULITZER PRIZE IN GENERAL NONFICTION The Undying is a startling, urgent intervention in our discourses about sickness and health, art and science, language and literature, and mortality and death. In dissecting what she terms 'the ideological regime of cancer,' Anne Boyer has produced a profound and unforgettable document on the experience of life itself. —Sally Rooney, author of Normal People Anne Boyer’s radically unsentimental account of cancer and the 'carcinogenosphere' obliterates cliche. By demonstrating how her utterly specific experience is also irreducibly social, she opens up new spaces for thinking and feeling together. The Undying is an outraged, beautiful, and brilliant work of embodied critique. —Ben Lerner, author of The Topeka School A week after her forty-first birthday, the acclaimed poet Anne Boyer was diagnosed with highly aggressive triple-negative breast cancer. For a single mother living paycheck to paycheck who had always been the caregiver rather than the one needing care, the catastrophic illness was both a crisis and an initiation into new ideas about mortality and the gendered politics of illness. A twenty-first-century Illness as Metaphor, as well as a harrowing memoir of survival, The Undying explores the experience of illness as mediated by digital screens, weaving in ancient Roman dream diarists, cancer hoaxers and fetishists, cancer vloggers, corporate lies, John Donne, pro-pain ”dolorists,” the ecological costs of chemotherapy, and the many little murders of capitalism. It excoriates the pharmaceutical industry and the bland hypocrisies of ”pink ribbon culture” while also diving into the long literary line of women writing about their own illnesses and ongoing deaths: Audre Lorde, Kathy Acker, Susan Sontag, and others. A genre-bending memoir in the tradition of The Argonauts, The Undying will break your heart, make you angry enough to spit, and show you contemporary America as a thing both desperately ill and occasionally, perversely glorious. Includes black-and-white illustrations |
| cancer is a business: A World Without Cancer Margaret I. Cuomo, 2013-10-01 A provocative and surprising investigation into the ways that profit, personalities, and politics obstruct real progress in the war on cancer—and one doctor's passionate call to action for change This year, nearly 1.6 million new cases of cancer will be diagnosed and more than 1,500 people will die per day. We've been asked to accept the disappointing strategy to manage cancer as a chronic disease. We've allowed pharmaceutical companies to position cancer drugs that extend life by just weeks and may cost $100,000 for a single course of treatment as breakthroughs. Why have we been able to cure and prevent other killer diseases but not most cancers? Where is the bold government leadership that will transform our system from treatment to prevention? Have we forgotten the mission of the National Cancer Act of 1971, to conquer cancer? Through an analysis of over 40 years of medical evidence and interviews with cancer doctors, researchers, drug company executives, and health policy advisors, Dr. Cuomo reveals frank and intriguing answers to these questions. She shows us how all cancer stakeholders—the pharmaceutical industry, government, physicians, and concerned Americans—can change the way we view and fight cancer in this country. |
| cancer is a business: The Unequal Burden of Cancer Institute of Medicine, Committee on Cancer Research Among Minorities and the Medically Underserved, 1999-06-11 We know more about cancer prevention, detection, and treatment than ever beforeâ€yet not all segments of the U.S. population have benefited to the fullest extent possible from these advances. Some ethnic minorities experience more cancer than the majority population, and poor peopleâ€no matter what their ethnicityâ€often lack access to adequate cancer care. This book provides an authoritative view of cancer as it is experienced by ethnic minorities and the medically underserved. It offers conclusions and recommendations in these areas: Defining and understanding special populations, and improving the collection of cancer-related data. Setting appropriate priorities for and increasing the effectiveness of specific National Institutes of Health (NIH) research programs, to ensure that special populations are represented in clinical trials. Disseminating research results to health professionals serving these populations, with sensitivity to the issues of cancer survivorship. The book provides background data on the nation's struggle against cancer, activities and expenditures of the NIH, and other relevant topics. |
| cancer is a business: The Cancer Book Geoffrey M. Cooper, 1993 Written in non-technical language, this book helps the reader understand the basic nature and causes of cancer, as well as the principles underlying current strategies for cancer prevention and treatment. By presenting an overview and perspective of both the basic and practical aspects of cancer, including the background needed to understand continuing advances in the field. The book is fascinating reading and an ideal book for everyone interested in the subject. |
| cancer is a business: Malignant Vinayak K. Prasad, 2020-04-21 This well-written, opinionated, and engaging book explains what we can do differently to make serious and sustained progress against cancer—and how we can avoid repeating the policy and practice mistakes of the past. |
| cancer is a business: NCI Fact Book National Cancer Institute (U.S.), 1979 |
| cancer is a business: Cancer and Society Eric H. Bernicker, 2019-03-04 While a number of books have looked at the intersection between human health in general and other topics, such as climate change or diet, this book focuses specifically on cancer as it impacts and is impacted by social justice issues. The massive explosion of research knowledge of cancer immunology and genomics is holding out great promise of therapeutic advances, yet other human actions—climate change, pollution, business decisions, advertising – are fostering health inequalities as well as increasing risks. Those involved in cancer care and research are in a unique position to let their experiences and knowledge inform the public, yet very often have not taken strong public roles when it comes to discussing issues surrounding tobacco, climate change and health risks, financial toxicity of treatments, and diet choices. Written by a multidisciplinary team of authors and for medical oncologists, cancer researchers, occupational health workers, and related medical students, residents, and fellows, this book encourages oncologists to address public health care and the societal issues associated with cancer risk. This volume discusses the overarching theme of environmental justice and oncology, focuses on business and cancer (such as clinical trials, drug development and profits, and global disparities), as well as animals and cancer. |
| cancer is a business: The Truth about Cancer Ty M. Bollinger, 2018-10-09 Cancer touches more lives than you may think. According to the World Health Organization, one out of three women alive today, and one out of two men, will face a cancer diagnosis in their lifetime.To Ty Bollinger, this isn’t just a statistic. It’s personal. After losing seven members of his family to cancer over the course of a decade, Ty set out on a global quest to learn as much as he possibly could about cancer treatments and the medical industry that surrounds the disease. He has written this book to share what he’s uncovered—some of which may shock you—and to give you new resources for coping with cancer in your life or the life of someone you love.As Ty explains, there are many methods we can access to treat and prevent cancer that go well beyond chemotherapy, radiation, and surgery; we just don’t know about them. The Truth about Cancer delves into the history of medicine—all the way back to Hippocrates’s credo of do no harm—as well as cutting-edge research showing the efficacy of dozens of unconventional cancer treatments that are helping patients around the globe. You’ll read about the politics of cancer; facts and myths about its causes (a family history is only part of the picture); and the range of tools available to diagnose and treat it.If you’re facing a cancer diagnosis right now, this book may help you and your health-care provider make choices about your next steps. If you’re already undergoing conventional treatment, it may help you support your health during the course of chemo or radiation. If you’re a health-care provider and want to learn all you can to help your patients, it will expand your horizons and inspire you with true stories of successful healing. And if you just want to see cancer in a new light, it will open your eyes. |
| cancer is a business: Highlights of Progress in Research on Cancer , 1957 |
¿Qué es el cáncer? - National Cancer Institute
Definición de cáncer, explicación breve de cómo se origina el cáncer en las células del cuerpo, estadísticas básicas de cáncer y enlaces a otros recursos del NCI.
Cancer - Symptoms and causes - Mayo Clinic
Nov 19, 2024 · Causes. Cancer is caused by changes (mutations) to the DNA within cells. The DNA inside a cell is packaged into a large number of individual genes, each of which contains …
Cancer - Wikipedia
Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. [2] [7] These contrast with benign tumors, which do not …
Cancer: Types, Causes, Treatment, and Prevention - Healthline
Jan 17, 2023 · Cancer is a group of diseases that occur when abnormal cells divide rapidly and spread. Learn the types, causes, treatments, and prevention methods.
Comprehensive Cancer Information - NCI
NCI is the nation’s trusted source for cancer information. We are here for you with information about causes and risk factors, symptoms, how cancer is diagnosed, and treatment options.
Cancer - World Health Organization (WHO)
Feb 3, 2025 · Key facts. Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths. The most common cancers are breast, …
End Cancer As We Know It | American Cancer Society
Dedicated to helping people who face cancer. Learn about cancer research, patient services, early detection, treatment and education at cancer.org.
Cancer - Wiley Online Library
1 day ago · Cancer is an international interdisciplinary journal publishing articles on the latest clinical cancer research findings, spanning the breadth of oncology disciplines.
Cáncer en español - National Cancer Institute
Las terapias combinadas con la QETA son eficaces para tratar el cáncer de hígado. Se observaron resultados favorables en dos estudios en los que se combinó un procedimiento …
What Is Cancer? | Cancer Basics - American Cancer Society
Cancer is a group of diseases where abnormal cells grow out of control and crowd out normal cells. It affects 1 in 3 people in the United States. Chances are that you or someone you know …
¿Qué es el cáncer? - National Cancer Institute
Definición de cáncer, explicación breve de cómo se origina el cáncer en las células del cuerpo, estadísticas básicas de cáncer y enlaces a otros recursos del NCI.
Cancer - Symptoms and causes - Mayo Clinic
Nov 19, 2024 · Causes. Cancer is caused by changes (mutations) to the DNA within cells. The DNA inside a cell is packaged into a large number of individual genes, each of which contains …
Cancer - Wikipedia
Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. [2] [7] These contrast with benign tumors, which do not …
Cancer: Types, Causes, Treatment, and Prevention - Healthline
Jan 17, 2023 · Cancer is a group of diseases that occur when abnormal cells divide rapidly and spread. Learn the types, causes, treatments, and prevention methods.
Comprehensive Cancer Information - NCI
NCI is the nation’s trusted source for cancer information. We are here for you with information about causes and risk factors, symptoms, how cancer is diagnosed, and treatment options.
Cancer - World Health Organization (WHO)
Feb 3, 2025 · Key facts. Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths. The most common cancers are breast, …
End Cancer As We Know It | American Cancer Society
Dedicated to helping people who face cancer. Learn about cancer research, patient services, early detection, treatment and education at cancer.org.
Cancer - Wiley Online Library
1 day ago · Cancer is an international interdisciplinary journal publishing articles on the latest clinical cancer research findings, spanning the breadth of oncology disciplines.
Cáncer en español - National Cancer Institute
Las terapias combinadas con la QETA son eficaces para tratar el cáncer de hígado. Se observaron resultados favorables en dos estudios en los que se combinó un procedimiento …
What Is Cancer? | Cancer Basics - American Cancer Society
Cancer is a group of diseases where abnormal cells grow out of control and crowd out normal cells. It affects 1 in 3 people in the United States. Chances are that you or someone you know …
